Side-by-side comparison of AI visibility scores, market position, and capabilities
Wealth and asset management with $17.1B FY2024 revenue; 10,000 advisors; Columbia Threadneedle $700B+ AUM; CEO Jim Cracchiolo 20-year tenure; 80%+ earnings returned to shareholders.
Ameriprise Financial is a leading wealth management and asset management company, founded in 1894 as Investors Syndicate within American Express and spun off as an independent public company in 2005, headquartered in Minneapolis, Minnesota and trading on NYSE (AMP). For FY2024, Ameriprise generated approximately $17.1 billion in total revenues under CEO Jim Cracchiolo, who has led the company since its 2005 IPO and transformed it from a diversified financial services company into a focused wealth and asset management powerhouse. The company serves approximately 2 million individual, business, and institutional clients through its network of approximately 10,000 financial advisors and through Columbia Threadneedle Investments, its global asset management subsidiary managing over $700 billion in assets.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.